Journal of Clinical Pathology · 2000 · 330 citations · 13 references
There is considerable interlaboratory variability, especially in relation to the detection of breast cancers with low oestrogen receptor positivity, with a false negative rate of between 30% and 60%. This variability appears to be caused by minor differences in methodology that may be rectified by fine adjustment of overall technique.
13
Tamoxifen for early breast cancer: an overview of the randomised trials
The Lancet · 1998 · 4.1K citations
Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
D. Craig Allred, Jennet Harvey, Melora D. Berardo et al. · PubMed · 1998 · 2.2K citations
DM Barnes, WH Harris, Paul Smith et al. · British Journal of Cancer · 1996 · 245 citations · Full text
Oestrogen Receptor, Breast Oncology, Breast Cancer Patients +12